摘要
目的分析比较贝那普利片和替米沙坦片治疗高血压的临床疗效。方法自2010年10月至2012年2月，来我院就诊的120例原发性2～3级老年高血压患者，将受试者随机分为两组，一组使用贝那普利片治疗，另一组使用替米沙坦片治疗。两组患者均接受为期4周的治疗，每天于清晨和傍晚各测量1次肱动脉的血压，记录每次测量的结果，求出均值作为治疗前、后患者的血压，同时使用问卷调查的形式对患者生活质量调查。结果治疗了4周以后与治疗前进行比较，结果显示两组降压药均可有效降压，差异无显著性（P〉0．05）。结论贝那普利片、替米沙坦片均能有效降低血压，但是替米沙坦片不良反应较少，能够较好地保护靶器官，适用于治疗老年人高血压。
Objective To analyze the efficacy of benazepri and telmisartan in the treatment of hypertension. Methods 120 elderly patients with stages II to III primary t hypertension who had visited our hospital during the period of October 2010 to February 2012 were randomly assigned to receive benazepril tablets or telmisartan tablets for four weeks. Brachial blood pressure was measured every morning and evening and the results of measurement were noted. Mean values were counted to use for patient blood pressure before and after treatment. A questionnaire survey on quality of life in patients was conducted. Results Four weeks after treatment, both benazepril and telmisartan effectively lowered blood pressure, with no significant difference in the efficacy （ P 〉 0.05 ）. Conclusions Either benazepril or telmisartan tablets can effec- tively lower blood pressure; however, telmisartan has fewer adverse reactions and better protect the target organs, which is suitable for elderly patients.
出处
《国际医药卫生导报》
2012年第23期3444-3446,共3页
International Medicine and Health Guidance News
关键词
贝那普利片
替米沙坦片
高血压
Benazepril tablets
Telmisartan tablets
Hypertension
